- Home
- RFMZ vs TKNO Comparison
RFMZ vs TKNO Comparison
Compare RFMZ & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RFMZ | TKNO |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.4M | 308.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RFMZ | TKNO |
|---|---|---|
| Price | $13.51 | $5.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.0K | ★ 233.6K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $12.30 | $1.91 |
| 52 Week High | $13.70 | $6.68 |
Technical Indicators
Market Signals| Indicator | RFMZ | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 56.38 |
| Support Level | $13.49 | $4.89 |
| Resistance Level | $13.51 | $5.94 |
| Average True Range (ATR) | 0.10 | 0.42 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 9.52 | 37.72 |
Price Performance
Historical ComparisonAbout RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.